PDS Biotechnology Corp. (PDSB)
1.07
-0.09
(-7.76%)
USD |
NASDAQ |
Oct 23, 11:26
PDS Biotechnology Price : 1.07 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | 1.16 | 1.22 | 1.115 | 1.16 | 5.123M |
| Oct 21, 2026 | 0.9982 | 1.31 | 0.99 | 1.24 | 15.24M |
| Oct 20, 2026 | 0.93 | 0.9861 | 0.90 | 0.9605 | 4.093M |
| Oct 19, 2026 | 1.13 | 1.14 | 0.9165 | 0.9165 | 8.432M |
| Oct 16, 2026 | 1.25 | 1.26 | 1.090 | 1.13 | 6.936M |
| Oct 15, 2026 | 1.371 | 1.39 | 1.095 | 1.30 | 10.23M |
| Oct 14, 2026 | 1.60 | 1.67 | 1.38 | 1.41 | 9.458M |
| Oct 13, 2026 | 1.43 | 1.79 | 1.39 | 1.60 | 16.97M |
| Oct 12, 2026 | 1.485 | 1.55 | 1.38 | 1.52 | 15.08M |
| Oct 09, 2026 | 1.04 | 1.40 | 1.00 | 1.38 | 16.06M |
| Oct 08, 2026 | 1.04 | 1.100 | 0.96 | 1.02 | 4.876M |
| Oct 07, 2026 | 1.05 | 1.10 | 1.00 | 1.065 | 5.605M |
| Oct 06, 2026 | 1.15 | 1.27 | 0.9361 | 1.045 | 17.04M |
| Oct 05, 2026 | 0.781 | 1.35 | 0.769 | 1.20 | 78.55M |
| Oct 02, 2026 | 0.715 | 0.7502 | 0.709 | 0.7485 | 3.657M |
| Oct 01, 2026 | 0.7499 | 0.76 | 0.7003 | 0.7061 | 3.726M |
| Sep 30, 2026 | 0.7244 | 0.7606 | 0.7101 | 0.7507 | 4.586M |
| Sep 29, 2026 | 0.7506 | 0.77 | 0.7292 | 0.7429 | 2.706M |
| Sep 28, 2026 | 0.7814 | 0.7895 | 0.7283 | 0.7659 | 4.042M |
| Sep 25, 2026 | 0.804 | 0.822 | 0.7805 | 0.7971 | 3.937M |
| Sep 24, 2026 | 0.81 | 0.81 | 0.75 | 0.8001 | 6.097M |
| Sep 23, 2026 | 0.88 | 0.9058 | 0.8176 | 0.8239 | 9.724M |
| Sep 22, 2026 | 0.86 | 0.995 | 0.812 | 0.91 | 24.75M |
| Sep 21, 2026 | 0.9371 | 0.97 | 0.8067 | 0.8419 | 17.07M |
| Sep 18, 2026 | 0.8225 | 0.90 | 0.7512 | 0.8055 | 18.98M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.72 |
| Alnylam Pharmaceuticals, Inc. | 223.72 |
| Anika Therapeutics, Inc. | 21.01 |
| Savara, Inc. | 4.24 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| Earnings Yield | -59.84% |
| Market Cap | 59.84M |